Anixa Biosciences is trading at $2.75, up 5.36%, with biotech-sector momentum offering a possible context for the move. - XBI was up 2.10% during regular trading. - No new company announcement was found for the October 20, 2026 session; the latest company news located was an October 13 conference announcement. - An investor webinar is scheduled for 4:15 p.m. ET today.